Regeneron Pharmaceuticals, Inc. $(REGN)$ is currently at $503.78, down $101.61 or 16.78%
--Would be lowest close since June 1, 2021, when it closed at $503.23
--On pace for largest percent decrease since April 29, 2011, when it fell 21%
--Currently down five of the past seven days
--Down 15.86% month-to-date; on pace for worst month since Oct. 2024, when it fell 20.27%
--Down 29.28% year-to-date
--Down 58.08% from its all-time closing high of $1201.76 on Aug. 27, 2024
--Down 48.60% from 52 weeks ago (May 31, 2024), when it closed at $980.16
--Down 58.08% from its 52-week closing high of $1201.76 on Aug. 27, 2024
--Would be a new 52-week closing low
--Traded as low as $493.15; lowest intraday level since May 27, 2021, when it hit $492.13
--Down 18.54% at today's intraday low; largest intraday percent decrease since April 29, 2011, when it fell as much as 21.45%
--Worst performer in the S&P 500 today
--Worst performer in the Nasdaq 100 today
All data as of 10:20:21 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 30, 2025 10:23 ET (14:23 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.